Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
"If Most Cancer Survivors Experience Fear of Cancer Recurrence, When Does it Become a Clinical Issue?: Expert Consensus Using a Delphi Method"
FY 2016-17
Summary
The current definition of fear of cancer recurrence (FCR) is “fear, worry, or concern about the cancer returning or progressing.”1 For most cancer survivors, FCR does not impact their daily life, but for some, worry about the cancer returning can become a clinical problem and difficult to manage.2 However, it is not known what characterizes clinical FCR.1,2 The purpose of this research study is to reach expert consensus on the defining features of clinical FCR. Experts will include international researchers and clinicians who actively study or treat FCR (i.e., oncology physicians and nurses, psychologists, etc.). Using an online modified Delphi method, experts will be asked to rate potential characteristics of clinical FCR on a scale from 0 (“Is not relevant to FCR”) to 4 (“Is an essential feature of FCR”). Consensus will be reached when at least 80% of experts rate a potential feature as a 3 or a 4. In Round 1, experts will be asked to rate a list of potential defining features of clinical FCR suggested by the literature, and will have the opportunity to suggest other features in an open text section of the online survey. In Round 2, participants will rate the features of clinical FCR suggested in the previous round. In Round 3, experts will be asked to re-rate items that were close to consensus (i.e., were rated as 3 or 4 by 70-79% of experts). Reaching consensus on the distinguishing features of clinical as opposed to non-clinical FCR is important for developing accurate screening tools to identify those who are experiencing it at clinical levels and who would benefit from psychosocial interventions.2 1. Lebel, S (2016). Supportive Care in Cancer, 24(8), 3265–3268 2. Lebel, S (2016). Psycho-Oncology. https://doi.org/10.1002/pon.4103
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367270
Name
Mutsaers Brittany
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
"If Most Cancer Survivors Experience Fear of Cancer Recurrence, When Does it Become a Clinical Issue?: Expert Consensus Using a Delphi Method"
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Survivorship; Clinical Fear Of Cancer Recurrence; Delphi Method; Expert Consensus; Psychosocial Oncology
Abstract
The current definition of fear of cancer recurrence (FCR) is “fear, worry, or concern about the cancer returning or progressing.”1 For most cancer survivors, FCR does not impact their daily life, but for some, worry about the cancer returning can become a clinical problem and difficult to manage.2 However, it is not known what characterizes clinical FCR.1,2 The purpose of this research study is to reach expert consensus on the defining features of clinical FCR. Experts will include international researchers and clinicians who actively study or treat FCR (i.e., oncology physicians and nurses, psychologists, etc.). Using an online modified Delphi method, experts will be asked to rate potential characteristics of clinical FCR on a scale from 0 (“Is not relevant to FCR”) to 4 (“Is an essential feature of FCR”). Consensus will be reached when at least 80% of experts rate a potential feature as a 3 or a 4. In Round 1, experts will be asked to rate a list of potential defining features of clinical FCR suggested by the literature, and will have the opportunity to suggest other features in an open text section of the online survey. In Round 2, participants will rate the features of clinical FCR suggested in the previous round. In Round 3, experts will be asked to re-rate items that were close to consensus (i.e., were rated as 3 or 4 by 70-79% of experts). Reaching consensus on the distinguishing features of clinical as opposed to non-clinical FCR is important for developing accurate screening tools to identify those who are experiencing it at clinical levels and who would benefit from psychosocial interventions.2 1. Lebel, S (2016). Supportive Care in Cancer, 24(8), 3265–3268 2. Lebel, S (2016). Psycho-Oncology. https://doi.org/10.1002/pon.4103
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mutsaers, Brittany
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~